Treatment of Rhabdomyolysis with Rash
The cornerstone of treatment for rhabdomyolysis with rash is aggressive intravenous fluid resuscitation, with high-dose corticosteroids indicated when the rash suggests an immune-mediated cause such as immune checkpoint inhibitor-induced myositis or dermatomyositis. 1, 2
Diagnosis and Assessment
- Rhabdomyolysis with rash may indicate immune-mediated myositis, particularly in patients receiving immune checkpoint inhibitors (ICPis), which can present with dermatomyositis-like features 2
- Laboratory assessment should include:
- Creatine kinase (CK) levels, which are typically markedly elevated (>5 times upper limit of normal) 1, 3
- Inflammatory markers (ESR, CRP) which are usually elevated in immune-mediated causes 2
- Electrolytes, particularly potassium, as hyperkalemia can lead to cardiac arrhythmias 1, 4
- Myoglobin levels in serum and urine 5
- Additional diagnostic tests may include:
- Autoantibody panels for myositis, though specific autoantibodies for ICPi-associated myositis are not well established 2
- MRI showing increased intensity and edema in affected muscles 2
- EMG which may show muscle fibrillations indicative of myopathy 2
- Muscle biopsy to confirm diagnosis in unclear cases 2
Treatment Algorithm
First-Line Treatment
Aggressive intravenous fluid resuscitation is the mainstay of treatment 1, 6
For cases with rash suggesting immune-mediated etiology:
Management of Complications
Assess for compartment syndrome 1, 2
- Early signs include pain, tension, paresthesia, and paresis 1
- Late signs include pulselessness and pallor, indicating irreversible damage 1
- Consider fasciotomy when compartment pressure exceeds 30 mmHg or when differential pressure is <30 mmHg 1
- Early fasciotomy is indicated for established compartment syndrome 1
For immune-related myositis with rash:
Special Considerations
For scorpion sting-induced rhabdomyolysis with rash:
For statin-induced rhabdomyolysis with rash:
Monitoring and Follow-up
- Repeated bioassessment should include plasma myoglobin, CK, and electrolyte measurements 1
- Continue intravenous fluids until CK levels are lower than 1,000 U/L 3
- For immune-mediated causes, monitor with serial examinations including inflammatory markers every 4-6 weeks after treatment initiation 2
- Most patients require hospital admission for monitoring and management 5
Pitfalls and Caveats
- Delayed treatment of rhabdomyolysis is associated with higher risk of acute kidney injury 1, 6
- Bicarbonate and mannitol do not have strong evidence for improved outcomes, though bicarbonate may be considered for patients who are acidotic 5, 6, 3
- In immune-mediated myositis with rash, myocardial involvement can be fatal and requires urgent treatment 2
- Patients with concomitant myasthenia gravis and myocarditis have high mortality rates 2
- Avoid medications that can exacerbate rhabdomyolysis, particularly succinylcholine 1